Angiotech Pharmaceuticals, Inc. Defers Payment, Seeks to Restructure Debt

TORONTO, Oct 1 (Reuters) - Canada’s Angiotech Pharmaceuticals (ANP.TO) is deferring $9.7 million in interest payments due Friday and is in talks with subordinated noteholders to refinance its debt.